Abuse Deterrent Opioids: Which Studies Will Show Real World Effect?

Experts suggest ways to assess impact of abuse deterrent opioid formulations at US FDA scientific workshop; showing statistical significance may not be possible.

Opioid abuse epidemic concept

FDA convened a diverse panel of experts to help piece together a "mosaic picture" of studies that might show whether opioids with abuse deterrent properties work in the real world. While the panelists didn't come up with definitive answers, they sketched ideas that may be used to improve the collection and analysis of data.

The July 10-11 scientific workshop focused on the current data resources used to investigate abuse deterrent formulations of opioids, and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Drug Safety

More from Pink Sheet

EU Medical Countermeasures Strategy Promises More AMR Pull Incentives

 

A new EU strategy to ensure access to essential medicines will boost the development of critical medical counter measures, including vaccines and therapies, according to one pharmaceutical industry group.

Animal Testing: US And EU Regulatory Support Grows For Alternatives, But Validation A Hurdle

 

In this first of a two-part series of articles, US Pharmacopeia CEO Ronald T. Piervincenzi tells the Pink Sheet how the use of alternatives to animal testing in drug development is gaining traction and discusses the challenges that exist.

Senate Panel Approves US CDC Director Candidate Monarez With Measles Outbreak Growing

 
• By 

The Senate Health, Education, Labor and Pensions Committee voted to advance Monarez's nomination to lead the CDC as the agency announced the largest US measles outbreak in 22 years.